Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple Anti-Inflammatory drug reduce dangerous side effects in End-Stage heart failure?

NCT ID NCT06062966

First seen Nov 17, 2025 · Last updated May 22, 2026 · Updated 21 times

Summary

This study tests whether a drug called anakinra can make the heart more sensitive to inotropes (medications that strengthen heart contractions) in people with advanced heart failure. By reducing inflammation, doctors hope to lower the dose of inotropes needed, which may decrease risks like irregular heartbeats and sudden death. The study involves 20 adults with stage D heart failure who are already on stable inotrope therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Virginia Commonwealth University

    RECRUITING

    Richmond, Virginia, 23284, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.